Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis

    NEXT STORY
    The 2019 U.S. HIV Market: Analyses & Forecasts Through 2014-2024
    PREV STORY
    AB Science reports the outcome from the interim analysis of study AB09004 in Alzheimer’s Disease
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Inventiva: H1 2019 financial results and corporate business update

    author_avatar
    NASDAQ Market News

    Genticel Appoints Remi Palmantier, PhD, as Chief Scientific Officer to Accelerate Its Development

    PARIS and TOULOUSE, France, Jan. 05, 2016 (GLOBE NEWSWIRE) -- Genticel (Euronext Paris & ...

    author_avatar
    NASDAQ Market News

    ContraFect to Present at the “Exploring the Antibiotic Pipeline 2018” Symposium and also to Present New Data on CF-301 (exebacase) at IDWeek 2018

    YONKERS, N.Y., Sept. 25, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology ...

    author_avatar
    NASDAQ Market News